Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 results ...

Nevro (NVRO) shares ended the last trading session 13.9% higher at $5.72. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session.

NEW YORK, NY / ACCESS Newswire / April 17, 2025 / Nevro Corp., recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals ...

NEWTOWN, Pa., April 10, 2025 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating claims regarding data privacy violations at Nevro Corp. (“Nevro”).

“We are excited to begin the journey of accelerating market penetration of Nevro’s differentiated high-frequency technology and bringing a much-needed treatment option to patients suffering ...

OKLAHOMA CITY, April 03, 2025 (GLOBE NEWSWIRE) -- Nevro Corp. investigated by Federman & Sherwood for data breach. On April 3, 2025, Nevro Corp. filed notice of a data breach with the Attorney ...

NEW YORK CITY, NY / ACCESS Newswire / April 10, 2025 / Nevro Corp.,recently disclosed that it suffered a data breach that compromised the sensitive personal and protected health data of individuals.